Predictive significance of stromal-associated lymphocytes in response to neoadjuvant chemotherapy in breast cancer
Menoufia Medical Journal · 2017 · 30 (4) · 1168
DOI: 10.4103/mmj.mmj_522_17 ↗Kurz gefasst
Fachartikel in der Zeitschrift Menoufia Medical Journal, 2017. Verfasst von AfafT Ibrahiem und 2 weiteren Autor:innen. Die Arbeit wurde bisher 2-mal zitiert (Crossref).
Themen: Onkologische Pflege
Abstract (Originalsprache)
ObjectiveIn this work, we aimed to assess whether the high stromal-associated lymphocytes and their subtypes in pretreatment core biopsies from patients with invasive breast carcinoma have a predictive role in pathologic response to neoadjuvant chemotherapy (NACT).BackgroundTumor-infiltrating lymphocytes including stromal-associated lymphocytes in breast cancer are considered a form of the host immune response to malignancy. Several studies suggested that tumor-infiltrating lymphocytes could predict better response to NACT, but their roles in predicting complete pathologic response (pCR) rate after NACT still needs further evaluation.Patients and methodsStromal-associated lymphocytes were evaluated in 100 pretreatment core biopsies from primary breast cancer patients eligible for NACT. Cases were defined as lymphocyte-rich if the percentage of lymphocytes was more than 50% and also the lymphocytes were evaluated for CD20, CD3, CD8, and CD4. Type of pathological response to NACT was determined in post-therapy surgical specimens of the same patients, and we correlated between type of response to stromal-associated lymphocytes and their subtypes.ResultspCR was detected in 22 (22%) breast cancer patients, partial pathologic response in 54 (54%), and no pathologic response in 24 (24%) patients. There was a significant association between percentage of stromal-associated lymphocytes and achievement of pCR rate (P = 0.006). In addition, high stromal-associated lymphocytes are significantly associated with advanced histological grade (P = 0.004), Ki-67 (P = 0.028), and negative estrogen receptor state (P = 0.015).ConclusionHigh stromal-associated lymphocytes and high percentage of CD8-positive T cells in stromal-associated lymphocytes could be reliable predictors for pCR rate after NACT.
Zitieren
APA
Ibrahiem, A., Mouhamed, H., & Anter, A. (2017). Predictive significance of stromal-associated lymphocytes in response to neoadjuvant chemotherapy in breast cancer. Menoufia Medical Journal, 30(4), 1168. https://doi.org/10.4103/mmj.mmj_522_17
Vancouver
Ibrahiem A, Mouhamed H, Anter A. Predictive significance of stromal-associated lymphocytes in response to neoadjuvant chemotherapy in breast cancer. Menoufia Medical Journal. 2017;30(4):1168. doi:10.4103/mmj.mmj_522_17
BibTeX
@article{Ibrahiem2017,
author = {Ibrahiem, AfafT and Mouhamed, HalaA and Anter, AbeerH},
title = {Predictive significance of stromal-associated lymphocytes in response to neoadjuvant chemotherapy in breast cancer},
journal = {Menoufia Medical Journal},
year = {2017},
volume = {30},
number = {4},
pages = {1168},
doi = {10.4103/mmj.mmj_522_17}
}
EUVIMED